A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedOBSERVATIONAL

Enrollment

11,296

Participants

Timeline

Start Date

June 10, 2019

Primary Completion Date

June 11, 2019

Study Completion Date

June 11, 2019

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Olodaterol/Tiotropium Bromide

(Stiolto®) delivered via Respimat inhaler

DRUG

Umeclidinium/ Vilanterol

(Anoro®) delivered via Ellipta Inhaler

Trial Locations (1)

Aetion Inc., New York